University of Cincinnati Clinical Research

trial

Phase 1 Experimental Trial Helps Patient With Advanced Liver Cancer

March 14, 2013

Posted in Patient Testimonials | Also tagged experimental, liver cancer |

Patients & Community
Back to UC Health

Search Clinical Studies

Search by Keyword Search by Category
Research in the News

Therapy After Surgical Removal of Rare Tumors May Not Increase Survival
Results of an analysis show that additional therapy delivered after surgicalremoval of a rare type of gastrointestinal tumor does not increase survivalrates for patients.
Get Involved in Research
Quick Links

About Uc Health

UC Health brings together the region’s top clinicians and researchers to provide world-class care to our community.

UC Health News
- What You Should Know About ImmunizationsApr 24, 2018
- UC Health Hosts 10th Annual Flag-Raising CeremonyApr 23, 2018
- Blood Bank Technician Works Like MagicApr 22, 2018

Colon Cancer Research Study

Looking at a Treatment to Reduce Colon Cancer Recurrence

What: The purpose of this study is to evaluate the effects of an oral drug called celecoxib when combined with FOLFOX chemotherapy in patients with colon cancer who have previously been treated with surgery. FOLFOX chemotherapy is a standard treatment used to prevent colon cancer from coming back and consists of three drugs: 5-fluorouracil, leucovorin and oxaliplatin. This study will also look at whether receiving FOLFOX for 6 treatments is as good as 12 treatments in preventing colon cancer from returning. Currently, the standard of care for colon cancer is 12 treatments with FOLFOX. This trial will explore whether 6 treatments are as effective as 12 treatments and whether side effects can be reduced with fewer treatments.

Who: Adults 18 years or older who have cancer of the colon, which has been surgically removed, but has spread to the lymph nodes may be eligible to participate.

Details:For more information, contact the UC Cancer Institute at kastla@ucmail.uc.edu or 513-584-7698.

© 2018 UC Health.